Back to Search Start Over

Iterum raises funds for new antibiotic.

Authors :
MCCOY, MICHAEL
Source :
C&EN Global Enterprise. 5/29/2017, Vol. 95 Issue 22, p14-15. 2p.
Publication Year :
2017

Abstract

The article reports that biotech firm Iterum Therapeutics has raised fund in series B Investment round and mentions that the cash will help the company to complete Phase III clinical trial of sulopenem which is antibiotic to treat Gram-negative multi-drug-resistant infection.

Subjects

Subjects :
*FUNDRAISING
*CLINICAL trials
*MULTIDRUG resistance

Details

Language :
English
ISSN :
24747408
Volume :
95
Issue :
22
Database :
Academic Search Index
Journal :
C&EN Global Enterprise
Publication Type :
Periodical
Accession number :
123480818
Full Text :
https://doi.org/10.1021/cen-09522-buscon007
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details